Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

  • Log out

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
  • Log out
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleResearch Letter

Interpersonal Continuity of Care May Help Delay Progression to Type 2 Diabetes

Bobbie L. Johannes, G. Craig Wood, Arch G. Mainous, Adam Cook, Alanna Kulchak Rahm, Christopher D. Still and Lisa Bailey-Davis
The Journal of the American Board of Family Medicine September 2024, 37 (5) 936-938; DOI: https://doi.org/10.3122/jabfm.2023.230382R2
Bobbie L. Johannes
From the Department of Population Health Sciences, Geisinger, Danville, PA (BLJ, LBD); Center for Obesity and Metabolic Health, Danville, PA (GCW, AC, CDS, LBD); Department of Health Services Research, Management and Policy, University of Florida, Health Sciences Center, Gainesville, FL (AGM); Geisinger Department of Genomic Health, Danville, PA 17822 (AKR); Division of Genomic Medicine, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD (AKR).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Craig Wood
From the Department of Population Health Sciences, Geisinger, Danville, PA (BLJ, LBD); Center for Obesity and Metabolic Health, Danville, PA (GCW, AC, CDS, LBD); Department of Health Services Research, Management and Policy, University of Florida, Health Sciences Center, Gainesville, FL (AGM); Geisinger Department of Genomic Health, Danville, PA 17822 (AKR); Division of Genomic Medicine, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD (AKR).
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arch G. Mainous III
From the Department of Population Health Sciences, Geisinger, Danville, PA (BLJ, LBD); Center for Obesity and Metabolic Health, Danville, PA (GCW, AC, CDS, LBD); Department of Health Services Research, Management and Policy, University of Florida, Health Sciences Center, Gainesville, FL (AGM); Geisinger Department of Genomic Health, Danville, PA 17822 (AKR); Division of Genomic Medicine, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD (AKR).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam Cook
From the Department of Population Health Sciences, Geisinger, Danville, PA (BLJ, LBD); Center for Obesity and Metabolic Health, Danville, PA (GCW, AC, CDS, LBD); Department of Health Services Research, Management and Policy, University of Florida, Health Sciences Center, Gainesville, FL (AGM); Geisinger Department of Genomic Health, Danville, PA 17822 (AKR); Division of Genomic Medicine, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD (AKR).
BA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alanna Kulchak Rahm
From the Department of Population Health Sciences, Geisinger, Danville, PA (BLJ, LBD); Center for Obesity and Metabolic Health, Danville, PA (GCW, AC, CDS, LBD); Department of Health Services Research, Management and Policy, University of Florida, Health Sciences Center, Gainesville, FL (AGM); Geisinger Department of Genomic Health, Danville, PA 17822 (AKR); Division of Genomic Medicine, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD (AKR).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher D. Still
From the Department of Population Health Sciences, Geisinger, Danville, PA (BLJ, LBD); Center for Obesity and Metabolic Health, Danville, PA (GCW, AC, CDS, LBD); Department of Health Services Research, Management and Policy, University of Florida, Health Sciences Center, Gainesville, FL (AGM); Geisinger Department of Genomic Health, Danville, PA 17822 (AKR); Division of Genomic Medicine, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD (AKR).
DO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa Bailey-Davis
From the Department of Population Health Sciences, Geisinger, Danville, PA (BLJ, LBD); Center for Obesity and Metabolic Health, Danville, PA (GCW, AC, CDS, LBD); Department of Health Services Research, Management and Policy, University of Florida, Health Sciences Center, Gainesville, FL (AGM); Geisinger Department of Genomic Health, Danville, PA 17822 (AKR); Division of Genomic Medicine, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD (AKR).
DEd
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Abstract

Background: The association between interpersonal continuity of care (CoC) and progression from the prediabetic state to Type 2 Diabetes (T2D) remains unknown.

Aim: To evaluate the association between interpersonal CoC and the progression to T2D among persons with prediabetes.

Design and Setting: A retrospective cohort study using electronic health record (EHR) data from 6620 patients at Geisinger, a large rural health care system in Danville, PA.

Methods: Cox regression methods were used to estimate the hazard ratio associated with progression to T2D within 3-years of being diagnosed with prediabetes.

Results: One additional visit with the primary care provider most frequently seen by the patient is associated with 14% decreased risk (HR = 0.86; 95% CI = 0.85, 0.87; P < .001) of transitioning to type 2 diabetes within 3 years of being diagnosed with prediabetes.

Conclusions: This study demonstrates an association between increased interpersonal CoC after a person is diagnosed with prediabetes and a reduced risk of progressing to T2D within 3 years.

  • Access to Primary Care
  • Continuity of Patient Care
  • Electronic Health Records
  • Prediabetic State
  • Primary Health Care
  • Retrospective Studies
  • Type 2 Diabetes Mellitus

Type 2 diabetes (T2D) is a leading cause of morbidity and mortality; progression to diabetes can be prevented with the detection of prediabetes and treatment.1⇓–3 Many modifiable risk factors for prediabetes and T2D can be addressed by primary care, such as obesity, hypertension, and smoking.4 However, a recent study found that there are numerous missed opportunities to screen, diagnose, and treat prediabetes among a cohort of primary care patients.5 One potential solution to earlier detection and treatment is interpersonal continuity of care (CoC)—a long-term relationship between a patient and a primary care clinician, that may be characterized by mutual trust and a shared sense of responsibility for care.6,7 Interpersonal CoC may improve the likelihood of patients being offered or referred treatment as well as compliance with treatment. Therefore, interpersonal CoC may lead to resolution of prediabetes or prevention of T2D.8 However, team-based care is becoming a standard practice for primary care, while this may foster chronological CoC, it may hinder interpersonal CoC and the value associated with seeing the same clinician throughout the duration of a chronic condition.9 The purpose of this study is to evaluate the association between interpersonal CoC and the progression to T2D among persons with prediabetes. We hypothesize that greater interpersonal CoC will be associated with lower risk of progression from prediabetes to T2D. This is the first study to assess interpersonal CoC among persons with prediabetes.

Methods

The sample comes from Geisinger’s Diabetes Risk Calculator which retrospectively identified 6620 patients with prediabetes through the Epic EHR.8 The sample was cared for by a total of 504 different clinicians at their index date, and 70 providers accounted for 50% of cases over the study period. The sample is predominantly non-Hispanic white (94%), 56% are female, and the median age at baseline was 55. Greater details on the study setting and inclusion and exclusion criteria are described elsewhere.8 Progression from prediabetes to T2D is defined as an HbA1c measure of ≥6.5% or a diagnosis of T2D. Interpersonal CoC is defined as the number of primary care visits with the clinician most frequently seen in the 3-year period after diagnosis with prediabetes until a diagnosis of T2D or until 3 years of follow-up had occurred. A value of zero is imputed for patients with no visits. We use cox regression methods to estimate the hazard ratios of progressing to T2D within 3-years of being diagnosed with prediabetes. We control for characteristics that put people at greater risk of progressing to T2D such as their initial HbA1c, baseline BMI, hypertension, and hyperlipidemia.10⇓⇓–13 Finally, we control for behavior and lifestyle changes (ie, weight loss and weight regain).14⇓⇓⇓⇓–18 This research was deemed not human subjects research due to the use of deidentified secondary data by Geisinger’s Institutional Review Board (# 2023-1041).

Results

One additional visit with the clinician most frequently seen is associated with 14% decreased risk of progressing to T2D within 3 years of being diagnosed with prediabetes (Table 1). Factors associated with higher risk of progression to T2D within 3 years included a higher HbA1c, BMI, and age at baseline. A percentage point increase in the amount of weight lost at 1-year post baseline is associated with 4% decreased risk of progressing to T2D within 3-years.

View this table:
  • View inline
  • View popup
Table 1.

Cox Regression Models Estimating the Hazard Ratios (HR) of Progressing to Type 2 Diabetes (T2D) within 3-Years of Being Diagnosed with Prediabetes

Limitations

This is a secondary analysis of a study population selected for the development of a Diabetes Risk Calculator; therefore, provider turnover is unknown. In addition, due to the high correlation between total primary care visits and interpersonal CoC, we were unable to control for both measures in our analyses.

Conclusions

We find that increased interpersonal CoC is associated with lower risk of progressing to T2D (as determined by HbA1c ≥6.5%) upon diagnosis of prediabetes. Similarly, a study by Mainous et al. (2004)18 found that persons with T2D had better HbA1c control if they had a usual source of care. Our findings suggest that interpersonal CoC may be associated with preventive benefit in the prediabetic state. These findings support the premise that more frequent visits with a single primary care clinician, and therefore, an opportunity to foster interpersonal CoC, may improve outcomes for persons with prediabetes and prevent the progression to T2D.

Notes

  • This article was externally peer reviewed.

  • Funding: The authors have no funding sources to report.

  • Conflict of interest: The authors have no conflicts of interest to declare.

  • To see this article online, please go to: http://jabfm.org/content/37/5/936.full.

  • Received for publication October 20, 2023.
  • Revision received November 19, 2023.
  • Revision received March 18, 2024.
  • Accepted for publication March 25, 2024.

References

  1. 1.↵
    1. Knowler WC,
    2. Barrett-Connor E,
    3. Fowler SE
    , Diabetes Prevention Program Research Groupet al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Davidson KW,
    2. Barry MJ,
    3. Mangione CM
    , US Preventive Services Task Forceet al. Screening for prediabetes and type 2 diabetes: US Preventive Services Task Force Recommendation Statement. JAMA 2021;326:736–43.
    OpenUrlCrossRefPubMed
  3. 3.↵
    World Health Organization. Diabetes 2023 [updated April 5, 2023; Accessed 2023 July 20]. Available at: https://www.who.int/news-room/fact-sheets/detail/diabetes.
  4. 4.↵
    1. Díaz-Redondo A,
    2. Giráldez-García C,
    3. Carrillo L,
    4. et al
    . Modifiable risk factors associated with prediabetes in men and women: a cross-sectional analysis of the cohort study in primary health care on the evolution of patients with prediabetes (PREDAPS-Study). BMC Fam Pract 2015;16:5.
    OpenUrlPubMed
  5. 5.↵
    1. Mainous AG 3rd.,
    2. Rooks BJ,
    3. Wright RU,
    4. Sumfest JM,
    5. Carek PJ
    . Diabetes prevention in a U.S. healthcare system: a portrait of missed opportunities. Am J Prev Med 2022;62:50–6.
    OpenUrlPubMed
  6. 6.↵
    1. Starfield B,
    2. Shi L,
    3. Macinko J
    . Contribution of primary care to health systems and health. MILBANK Q 2005;83:457–502.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Saultz JW
    . Defining and measuring interpersonal continuity of care. Ann Fam Med 2003;1:134–43.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Bailey-Davis L,
    2. Wood GC,
    3. Cook A,
    4. et al
    . Communicating personalized risk of diabetes and offering weight reduction program choice: recruitment, participation, and outcomes. Patient Educ Couns 2021;104:1193–9.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Wright M,
    2. Mainous A
    . Can continuity of care in primary care be sustained in the modern health system? Aust J Gen Pract 2018;47:667–9.
    OpenUrlPubMed
  10. 10.↵
    1. Hu S,
    2. Lin C,
    3. Cai X,
    4. et al
    . Trends in baseline HbA1c and body-mass index in randomised placebo-controlled trials of type 2 diabetes from 1987 to 2022: a systematic review and meta-analysis. eClinicalMedicine 2023;57:101868.
    OpenUrlPubMed
  11. 11.↵
    1. Guh DP,
    2. Zhang W,
    3. Bansback N,
    4. Amarsi Z,
    5. Birmingham CL,
    6. Anis AH
    . The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009;9:88.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Field AE,
    2. Coakley EH,
    3. Must A,
    4. et al
    . Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 2001;161:1581–6.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Wilson PW,
    2. D'Agostino RB,
    3. Sullivan L,
    4. Parise H,
    5. Kannel WB
    . Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002;162:1867–72.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Bailey-Davis L,
    2. Wood GC,
    3. Benotti P,
    4. et al
    . Impact of sustained weight loss on cardiometabolic outcomes. Am J Cardiol 2022;162:66–72.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Li G,
    2. Zhang P,
    3. Wang J,
    4. et al
    . The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 2008;371:1783–9.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Patel YR,
    2. Kirkman MS,
    3. Considine RV,
    4. Hannon TS,
    5. Mather KJ
    . Changes in weight and glucose can protect against progression in early diabetes independent of improvements in β-cell function. J Clin Endocrinol Metab 2016;101:4076–84.
    OpenUrlPubMed
  17. 17.↵
    1. Resnick HE,
    2. Valsania P,
    3. Halter JB,
    4. Lin X
    . Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults. J Epidemiol Community Health 2000;54:596–602.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Mainous AG 3rd.,
    2. Koopman RJ,
    3. Gill JM,
    4. Baker R,
    5. Pearson WS
    . Relationship between continuity of care and diabetes control: evidence from the Third National Health and Nutrition Examination Survey. Am J Public Health 2004;94:66–70.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

The Journal of the American Board of Family     Medicine: 37 (5)
The Journal of the American Board of Family Medicine
Vol. 37, Issue 5
September-October 2024
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Interpersonal Continuity of Care May Help Delay Progression to Type 2 Diabetes
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 15 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Interpersonal Continuity of Care May Help Delay Progression to Type 2 Diabetes
Bobbie L. Johannes, G. Craig Wood, Arch G. Mainous, Adam Cook, Alanna Kulchak Rahm, Christopher D. Still, Lisa Bailey-Davis
The Journal of the American Board of Family Medicine Sep 2024, 37 (5) 936-938; DOI: 10.3122/jabfm.2023.230382R2

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Interpersonal Continuity of Care May Help Delay Progression to Type 2 Diabetes
Bobbie L. Johannes, G. Craig Wood, Arch G. Mainous, Adam Cook, Alanna Kulchak Rahm, Christopher D. Still, Lisa Bailey-Davis
The Journal of the American Board of Family Medicine Sep 2024, 37 (5) 936-938; DOI: 10.3122/jabfm.2023.230382R2
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Limitations
    • Conclusions
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Clinically Relevant Family Medicine Research: Board Certification Updates
  • Google Scholar

More in this TOC Section

  • Timing of Certification Stage Completion Associated with Subsequent Certification Exam Outcomes Among Board-Certified Family Physicians
  • Impact of Point of Care Hemoglobin A1c Testing on Time to Therapeutic Intervention
Show more Research Letter

Similar Articles

Keywords

  • Access to Primary Care
  • Continuity of Patient Care
  • Electronic Health Records
  • Prediabetic State
  • Primary Health Care
  • Retrospective Studies
  • Type 2 Diabetes Mellitus

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire